Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0020538 (hypertension)
 170,190 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A 3- to 4-week exposure of rats to a cold environment (5 +/- 2 degrees C) induces hypertension, including elevation of systolic, diastolic, and mean blood pressures and cardiac (left ventricular) hypertrophy. The studies described here were designed to investigate some factors affecting both the magnitude and the time course for development of cold-induced hypertension. The objective of the first study was to determine whether there was an ambient temperature at which the cold-induced elevation of blood pressure did not occur. The objective of the second experiment was to determine whether body weight at the time of exposure to cold affected the magnitude and time course for development of hypertension. To assess the first objective, male rats were housed in a chamber whose temperature was maintained at 5 +/- 2 degrees C while others were housed in an identical chamber at 9 +/- 2 degrees C. After 7 days of exposure to cold, the rats exposed to the colder temperature had a significant elevation of blood pressure (140 +/- 2 mm Hg) compared with the group maintained at 9 degrees C (122 +/- 3 mm Hg). The rats exposed to 9 degrees C had no significant elevation of systolic blood pressure at either 27 or 40 days after initiation of exposure to cold. At the latter time, the temperature in the second chamber was reduced to 5 +/- 2 degrees C. By the 25th day of exposure to this ambient temperature, the rats had a significant increase in systolic blood pressure above their levels at 9 degrees C. Thus, there appears to be a threshold ambient temperature for elevation of blood pressure during exposure to cold. That temperature appears to lie somewhere between 5 and 9 degrees C. The second objective was assessed by placing rats varying in weight from approximately 250 to 430 g in air at 5 degrees C. There was a highly significant direct relationship (r = 0.96) between body weight at the time of introduction to cold and the number of days required to increase systolic blood pressure by 10 mm Hg above pre-cold exposure level. The third objective was to make an initial assessment of potential differences among strains of rats with respect to development of cold-induced hypertension. To this end, rats of the Fischer 344 strain were used. Systolic blood pressures of these rats also increased during chronic exposure to cold.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Factors affecting cold-induced hypertension in rats. 225 4

A 3-year-old boy presented with decreased renal function, hypertension, obesity and developmental delay. Evaluation of his kidneys revealed blunting of the calyces and multiple renal cortical cysts. Ophthalmologic evaluation showed no abnormalities on examination but electroretinography showed reduced retinal function suggesting a diffuse retinal disorder. Based on the clinical presentation with the associated abnormalities, the diagnosis of Bardet-Biedl syndrome, a form of the Laurence-Moon-Biedl syndrome was made. This syndrome should be considered and specific diagnostic efforts should be made in pediatric patients who present with renal failure and obesity.
 ...
PMID:Early diagnosis of Bardet-Biedl syndrome. 240 Jun 55

A 3 year old Chinese girl with watery diarrhoea, abdominal distension and hypokalaemia due to a thoracic paraspinal vasoactive intestinal peptide (VIP) secreting ganglioneuroma is reported. The pre-operative serum VIP was 314 pmol/l (normal less than 30). Her diarrhoea stopped after the removal of the tumour. The VIP was 14 pmol/l 6 months post-operatively. Review of the 19 reported cases in children with documented elevated serum VIP showed that many of the cases presented with watery diarrhoea for prolonged duration before the diagnosis was made. Earliest age of onset was 2 weeks of age. The male to female ratio was 9:10. Ganglioneuroma and ganglioneuroblastoma were the commonest tumours. Pancreatic non-beta cell hyperplasia and neurofibroma were also reported. Location of the tumour was variable: neck, chest or abdomen. Increased urinary catecholamine excretion was reported in 50% of the cases. Abdominal distension, flushing, episodic hypertension and failure to thrive were the other associated features.
 ...
PMID:Vasoactive intestinal peptide secreting tumours in children: a case report with literature review. 283 14

A case-control study of hypertension was conducted, using as a sampling frame a cross-sectional survey of Canadian Federal civil servants. Three case groups were selected, based on prior knowledge of hypertensive status and measured blood pressure. A 3-to-1 matching scheme was employed. Data was analysed using a logistic regression model. Statistically significantly elevated odds ratios, in excess of 3.0, were noted for overweight or obese status. Other odds ratios associated with a significantly increased risk of hypertension were maternal and paternal history of hypertension and current cigarette smoking.
 ...
PMID:Risk factors for hypertension: results from a cross-sectional survey. 325 59

Rats were exposed to alcohol vapor for 6 days and the mean blood ethanol concentration (BEC) was obtained for each subject. Blood pressure and its reactivity to noradrenaline and a thromboxane-mimic U46619 were directly measured on day 6 via a catheter implanted in the tail artery of normal and ethanol-treated animals. The mean BEC for each subject correlated with mean arterial blood pressure (MAP); an increase in BEC was associated with a decrease in MAP (p less than 0.02). The mean MAP of subjects with BEC less than 168 mg% was 8% higher than normal (not significant), whereas, the mean MAP of subjects with BEC greater than 182 mg% decreased 27 +/- 4% (p less than 0.01). Conversely, the pressor response to U46619 was markedly enhanced (p less than 0.005) in rats with mean BEC greater than 182 mg% at all doses investigated (12.5-3200 ng per rat). Increases in the pressor response to noradrenaline in ethanol-treated rats were significant only when maximally stimulated by 400 and 800 ng doses (p less than 0.03). A 3-fold increase in sensitivity for U46619 was seen in subjects with high mean BEC, however, sensitivity for noradrenaline did not significantly change. Vasoreactivity was not effected in rats with mean BEC less than 168 mg%. These data demonstrate that a moderate mean BEC for 6 days induces a tendency towards a mild hypertension, whereas, high mean BEC induces marked hypotension which is associated with hyperreactivity. Long-term exposure to high blood ethanol concentrations may predispose the alcohol-dependent rats to hypertensive disease and vasospastic disorders, at least partially, as a result of enhanced sensitivity to prostaglandins such as thromboxane.
 ...
PMID:The effect of chronic alcohol inhalation on blood pressure and the pressor response to noradrenaline and the thromboxane-mimic U46619. 376 8

The antihypertensive effect of oral labetalol and propranolol were evaluated in 65 black and 75 white patients with mild to moderate hypertension (standing diastolic blood pressure (StDBP) of 90-115 mmHg) in a double-blind multicenter clinical trial. Following a 4-week placebo phase, labetalol (n = 70) or propranolol (n = 70) was randomly assigned. During a 5-week titration phase, labetalol could be increased from 100 mg BID to 600 mg BID to achieve a StDBP of less than 90 mmHg and a decrement of greater than or equal to 10 mmHg. Propranolol could be titrated from 40 to 240 mg BID. A 3-month maintenance phase was followed by an optional 8-month maintenance phase. Hydrochlorothiazide (HCTZ) could be added at any time during the maintenance phase. Supine and standing blood pressures were measured at each visit. Statistical analysis revealed significant (ANOVA, p less than 0.05) treatment by race effects. Therefore, the treatment groups were stratified retrospectively by race. This study demonstrated that labetalol is equally effective in white and black patients, whereas, propranolol is significantly (p less than 0.05) more effective in white than in black patients. Moreover, labetalol is significantly more effective than propranolol in lowering the standing systolic/diastolic blood pressure of black patients (p less than 0.02/p less than 0.001). These blood-pressure effects were accompanied by a significantly greater (p less than 0.04) reduction in heart rate with propranolol. Furthermore, significantly more (p less than 0.05) black patients treated with propranolol compared to those treated with labetalol required the addition of a diuretic for control of their blood pressure.
 ...
PMID:Monotherapy with labetalol compared with propranolol. Differential effects by race. 391 17

A 3-year prospective study was undertaken to evaluate the relationship between plasma renin activity levels and the incidence of cardiovascular complications in white patients with uncomplicated essential hypertension treated with various beta-adrenergic blocking agents (oxprenolol, pindolol, propranolol, sotalol and timolol). During the follow-up study, 4 (5.9%) of 68 treated patients and 10 (41.7%) of 24 non-treated patients (p less than 0.001) developed cardiovascular complications. The cardiovascular events occurred more frequently in patients with low renin activity levels and in patients with severe hypertension (diastolic blood pressure above 120 mmHg). An increase in plasma renin activity levels was observed following cardiovascular complications in both groups of patients. No cases of myocardial infarction occurred among the treated patients, while 5 cases (3 fatal) of proven myocardial infarction occurred among the non-treated patients. The results of this study suggest that low plasma renin activity levels have no "protective effect" on the incidence of cardiovascular complications in patients with essential hypertension. The fact that no cases of myocardial infarction were observed among patients treated with various beta-adrenergic blocking drugs suggests that these drugs may have a "cardioprotective" effect on ischaemic heart disease in patients with essential hypertension. This hypothesis should be confirmed by further trials.
 ...
PMID:Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs. 611 13

We studied prostaglandins and kallikrein urinary excretion in 14 children with acute poststreptococcal glomerulonephritis within 48 hours of hospital admission (period A), and again, 4-6 weeks later, when they were clinically recovered (period B). Seventeen apparently healthy children were studied as controls. The results (mean +/- SEM) indicate that PGE2 urinary excretion (ng/kg/day) was diminished during both periods of study (control group = 2.06 +/- 0.43, patients = period A 0.91 +/- 0.28 [P less than 0.02], period B 0.92 +/- 0.21 [P less than 0.02]). PGF2 alpha urinary excretion (ng/kg/day) was also suppressed during period A, but not during period B when large individual variability existed (control group = 7.10 +/- 1.07, patients period A 3.56 +/- 0.66 [P less than 0.001], period B 10.51 +/- 5.01 [NS]). Kallikrein urinary excretion (EU/kg/day) was also depressed during the acute phase and remained low during convalescence (control group = 0.492 +/- 0.1, patients period A 0.143 +/- 0.044 [P less than 0.001], period B 0.265 +/- 0.093 [P less than 0.02]). There was no difference in PGE/PGF ratio between controls and patients in the periods of study (control 0.328 +/- 0.055, period A 0.395 +/- 0.144, period B 0.384 +/- 0.128). Urine volume (ml/day) was lower in period A (582 +/- 75.8) but comparable in period B (1020 +/- 140.2) and control children (1210 +/- 80.2). No correlation could be found between the urinary excretion of PGE2, PGF2 alpha and kallikrein with any of the following parameters: urinary or serum sodium and potassium, serum or urinary osmolality, Cosm, urine flow, plasma renin activity, plasma or urinary aldosterone, hypertension or fluid retention.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Urinary excretion of prostaglandins (PGE2 and PGF2 alpha) and kallikrein in acute glomerulonephritis. 658 Sep 82

A 3-year survey of patient referrals and case material in pediatric nephrology is evaluated to provide a data base for future projection of patient needs. In the 3-year period between January 1978 to December 1980, 538 pediatric patients with renal and electrolyte disorders were evaluated and treated. The principle reasons for the referrals were: hematuria (23%), hypertension (5%), nephrotic syndrome (7%), non-acute glomerulopathies (11%), acute glomerulonephritis (3%), fluid-electrolyte disorders (29%), urinary tract infections (6%), and others. Of the 538 patients, 99 underwent percutaneous renal biopsies under ultrasound guidance. The indications and results of the renal biopsies were also reviewed. The accrual of 18 chronic dialysis patients over a 36-month period is analyzed and presented. The ages of the patients were 4 to 16 years. They weighed from 16 to 51 kg. The primary renal diseases were objective uropathy, chronic glomerulonephritis, membrano-proliferative nephritis, chronic pyelonephritis, focal glomerulonephritis, lupus nephritis and others. All children, except 9 received kidney transplantations. The annual incidence of end-stage renal failure was 4 per million population.
 ...
PMID:A 3-year survey of referral pattern and case material in pediatric nephrology. 734 35

To investigate the mechanisms that sustains arterial hypertension in chronic uremia we performed hemodynamic studies in 13 dialysed uremics by means selective radiocardiography (Donato-Giuntini method). The 5 dialysed patients with dialysis controllable hypertension (GROUP B) had higher cardiac indexes (CI) respect to the 8 dialysed normotensive controls (GROUP A) (CI: Group B 4,250 l/min/m2, Group A 3,610 l/min/m2; p less than 0,05). The higher CI in group B appeared independent from the degree of anemia because the two groups had comparable hematocrit values (Hct:Group B 26,2% Group A 26,4%); On the other hand the slight blood volume expansion we observed in group B (7%) respect to group A hardly explains the observed difference in CI. It is interesting that pulmonary blood volume/total blood volume ratio (PBV/TBV) was significantly higher in dialysed hypertensives (PBV/TBV: Group B 14,26%, Group A 11,15%; p less than 0,05) The higher PBV/TBV can be the result of a decrease in venous compliance and could explain the higher CI in group B; further studies however are warranted to elucidate this point.
 ...
PMID:[Cardiac output and pulmonary blood volume in arterial hypertension of chronic uremia]. 747 Feb 87


<< Previous 1 2 3 4 5 6 7 Next >>